Hair Million, for hair growth




DreamPharm Products:

Lutein-20||Herbs for headache, fever, and migraine || Milk thistle||Saw palmetto|| Triple B Super Vision||Garlic, Ginger, and Grapeseed Extract|| Ginseng and Ginkgo||Hair Million|| DHEA||Coenzyme Q10|| Sleep Aid herbal formula - natural sleep aid||Herbal Breath - herbs for bad breath problems.|| Weight loss herbal formula for menopause and pms||Ginkgo biloba|| Colon cleansing, Laxative||ViaVita, Lecithin for healthy liver

Interferon research abs 1 || Hemoglobin research abs || Stem cell research abs || Nucleic acid research abs || Herpes research abs || Bronchitis research abs || Schizophrenia research abs







  • Visual feature conjunction in patients with schizophrenia: an event-related brain potential study.
  • Procedural learning in schizophrenia: a functional magnetic resonance imaging investigation.
  • Caregivers' stresses when living together or apart from patients with chronic schizophrenia.
  • Schizophrenia-like illness in velo-cardio-facial syndrome: a genetic subsyndrome of schizophrenia?
  • Training nurses to support carers of relatives with schizophrenia.
  • Semantic clustering in verbal fluency: schizophrenic patients versus control participants.
  • Volumetric magnetic resonance imaging study of the anterior cingulate gyrus in schizotypal disorder.
  • Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats.
  • Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.
  • Biological markers and possibilities for predicting therapeutic results in schizophrenia: a methodological contribution.
  • Schizophrenia is a caused by patient's prefrontal lobe becoming inert and inactive!
  • Implementing assertive community care for patients with schizophrenia. A case study of co-operation and collaboration between mental health care and social services.
  • Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
  • Decreased phorbol ester binding in the parahippocampal gyrus from subjects with schizophrenia is not associated with changes in protein kinase C.
  • A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27.
  • Summer birth and deficit schizophrenia: Cantabria, Spain.
  • Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry.
  • abst 116
  • Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system.
  • A longitudinal study of the effects of seizure symptoms on the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) clinical interpretation.
  • Schizophrenia and other mental disorders require long-term adoptive immunotherapy.
  • Idiom processing in schizophrenia: literal implausibility saves the day for idiom priming.
  • Biochemical effects in brain of low doses of haloperidol are qualitatively similar to those of high doses.
  • Association analysis of an (AC)n repeat polymorphism in the GABA(B) receptor gene and schizophrenia.
  • Alteration of branch site consensus sequence and enhanced pre-mRNA splicing of an NMDAR1 intron not associated with schizophrenia.
  • Acute renal failure in neuroleptic malignant syndrome.
  • Progressive onset of adrenal insufficiency and hypogonadism of pituitary origin caused by a complex genetic rearrangement within DAX-1.
  • abst 125
  • White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders.
  • PRODH mutations and hyperprolinemia in a subset of schizophrenic patients.
  • Is double diagnosis appropriate? A case of schizophrenia and heroine addiction
  • Clozapine intoxication in a dog.
  • Smaller frontal gray matter volume in postmortem schizophrenic brains.
  • The association between schizophrenia and cancer: a population-based mortality study.
  • Seasonal fluctuation in birthweight in schizophrenia.
  • The dichotomy of schizophrenia and affective disorders in extended pedigrees.
  • Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity.
  • Maternal bonding behaviour in schizophrenia and schizoaffective disorder, considering premorbid personality traits.
  • Effect of exercise on motor evoked potentials elicited by transcranial magnetic stimulation in psychiatric patients.
  • Neighborhood structural characteristics and mental disorder: Faris and Dunham revisited.
  • Influence of attention on an auditory-verbal learning test in schizophrenic patients
  • Clinical and prognostic significance of seasonal factor in endogenous maniac states
  • Deficits in automatically detecting changes in conjunction of auditory features in patients with schizophrenia.
  • An association of CAG repeats at the KCNN3 locus with symptom dimensions of schizophrenia.
  • Clozapine in patients with chronic schizophrenia: serum level, EEG and memory performance.
  • Attitudes about schizophrenia from the pilot site of the WPA worldwide campaign against the stigma of schizophrenia.
  • Decreased density of 3HTCP binding following antipsychotic drug withdrawal in rats.
  • Computed tomography of the brain morphology of patients with first-episode schizophrenic psychosis.
  • First-episode schizophrenia, bipolar disorder and other psychoses in a rural Irish catchment area: incidence and gender in the Cavan-Monaghan study at 5 years.
  • Structural magnetic resonance imaging in patients with first-episode schizophrenia, psychotic and severe non-psychotic depression and healthy controls. Results of the schizophrenia and affective psychoses (SAP) project.
  • Cloning and characterization of Disc1, the mouse ortholog of DISC1 (Disrupted-in-Schizophrenia 1).
  • Interactions between health and population
  • A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission.
  • Thought and Language Index: an instrument for assessing thought and language in schizophrenia.
  • Schizophrenic subjects show deficient inhibition but intact task switching on saccadic tasks.
  • Family history study of posttraumatic stress disorder with secondary psychotic symptoms.
  • Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics.
  • Association analysis of polymorphic CGG repeat in 5' UTR of the reelin and VLDLR genes with schizophrenia.
  • Cerebral metabolism and risperidone treatment in schizophrenia.
  • Mutational analysis of the connexin 36 gene (CX36) and exclusion of the coding sequence as a candidate region for catatonic schizophrenia in a large pedigree.
  • Incidental radiological findings on brain magnetic resonance imaging in first-episode psychosis and chronic schizophrenia.
  • Living situation, subjective quality of life and social network among individuals with schizophrenia living in community settings.
  • Maintenance therapy in schizophrenia: a critical comment.
  • Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors.
  • Predictors for hospitalization rates of patients with schizophrenia
  • Changes in central serotonergic function as a correlate of duration of illness in paranoid schizophrenia.
  • Craniofacial dysmorphogenesis in fetally irradiated nonhuman primates: implications for the neurodevelopmental hypothesis of schizophrenia.
  • Visual processing and neuropsychological function in schizophrenia and schizoaffective disorder.
  • Norepinephrine transporter gene polymorphism is not associated with susceptibility to alcohol dependence.
  • Heavy users of inpatient psychiatric services
  • The risk of rehospitalisation during therapy with atypical and typical neuroleptics--a contribution to differential indication
  • Source monitoring impairments in schizophrenia: characterisation and associations with positive and negative symptomatology.
  • Asymmetry of the uncinate fasciculus: a post-mortem study of normal subjects and patients with schizophrenia.
  • Differential effects of chronic haloperidol and clozapine administration on glutamatergic transmission in the fronto-parietal cortex in rats: microdialysis and electrophysiological studies.
  • Diagnostic, symptomatic and sanitary assessment of schizophrenic patients in Liege psychiatric institutions
  • Statistical parametric mapping of LORETA using high density EEG and individual MRI: application to mismatch negativities in schizophrenia.
  • Delusional disorder: molecular genetic evidence for dopamine psychosis.
  • Localisation of the GPRC5B receptor in the rat brain and spinal cord.
  • Novelty detection and repetition suppression in a passive picture viewing task: a possible approach for the evaluation of neuropsychiatric disorders.
  • Elevated expression of integrin alpha(IIb) beta(IIIa) in drug-naive, first-episode schizophrenic patients.
  • State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia.
  • A highly significant association between a COMT haplotype and schizophrenia.
  • Plasma serotonin response to carbohydrate-rich food in chronic schizophrenic patients: clozapine versus classic antipsychotic agents.
  • Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia.
  • A preliminary study of the comparative effects of olanzapine and fluphenazine on cognition in schizophrenic patients.
  • Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.
  • A five year follow-up study of the use of clozapine in community practice.
  • Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping.
  • 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.
  • A functional anatomic study of emotion in schizophrenia.
  • Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up study.
  • Women with schizophrenia: pregnancy outcome and infant death among their offspring.
  • Interpersonal control, expressed emotion, and change in symptoms in families of persons with schizophrenia.
  • Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.
  • Insight in schizophrenia: associations with executive function and coping style.
  • Working memory and schizophrenia: evidence for slowed encoding.
  • Auditory P300 amplitude as a state marker for positive symptoms in schizophrenia: cross-sectional and retrospective longitudinal studies.
  • Increased automatic spreading of activation in thought-disordered schizophrenic patients.
  • Childhood-onset schizophrenia: premorbid and prodromal diagnostic and treatment histories.
  • Neurocognition and community outcome in schizophrenia: long-term predictive validity.
  • Visual object working memory function and clinical symptoms in schizophrenia.
  • Learning (potential) and social functioning in schizophrenia.
  • Is response to prophylactic lithium a familial trait?
  • Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia.
  • Dissolution profile, tolerability, and acceptability of the orally disintegrating olanzapine tablet in patients with schizophrenia.
  • Readmission risk in schizophrenia: selection explains previous findings of a progressive course of disorder.
  • Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data.
  • Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert.
  • Lack of self-control as assessed by a personality inventory is related to reduced volume of supplementary motor area.
  • P50 sensory gating in multiplex schizophrenia families from a Pacific island isolate.
  • abst 4 abst 4
  • A magnetization transfer analysis of the thalamus in schizophrenia.
  • A computational morphometric MRI study of schizophrenia: effects of hallucinations.
  • Psychometric schizotypy and motor performance.
  • Antipsychotic, antidepressant, anxiolytic, and anticonvulsant drugs induce type II nitric oxide synthase mRNA in rat brain.
  • Vitamin D3 and brain development.
  • Co-catalytic metallopeptidases as pharmaceutical targets.
  • Cerebral metabolic patterns in chronic and recent-onset schizophrenia.
  • Redefining parental identity: caregiving and schizophrenia.
  • Mentally-ill patients charged with homicide.
  • Reducing mental illness stigma and discrimination - everybody's business.
  • The temporal lobe in schizophrenia from uni- and multiply affected families.
  • Medical comorbidity in schizophrenia.
  • Pre-therapy: a newer development in the psychotherapy of schizophrenia.
  • Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study.
  • Questions and answers for the advanced practice psychiatric nurse.
  • Machiavellianism and Theory of Mind in people affected by schizophrenia.
  • Functional disconnection between the prefrontal and parietal cortices during working memory processing in schizophrenia: a15(O)H2O PET study.
  • The Maudsley early onset schizophrenia study: cognitive function in adolescents with recent onset schizophrenia.
  • Methodological considerations regarding the association of Stroop and verbal fluency performance with the symptoms of schizophrenia.
  • Abnormal motor asymmetry only during bimanual movement in schizophrenic patients compared with healthy subjects.
  • Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation.
  • Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study.
  • Neonatal lesions in the amygdala or ventral hippocampus disrupt prepulse inhibition of the acoustic startle response; implications for an animal model of neurodevelopmental disorders like schizophrenia.
  • CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
  • Association between regional cerebral blood flow and eye-tracking performance and the Wisconsin Card Sorting Test in schizophrenics: a single photon emission computed tomography study.
  • Cognitive rehabilitation with patients having persistent, severe psychiatric disabilities.
  • On the broad applicability of the affective circumplex: representations of affective knowledge among schizophrenia patients.
  • Psychiatric and social outcomes of a rural district general hospital in the 1990s.
  • Disruption of the neuronal PAS3 gene in a family affected with schizophrenia.
  • A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.
  • Aging and outcome in schizophrenia.
  • Prenatal underdevelopment and schizophrenia: a case report of monozygotic twins.
  • Depressive disorders in spouses of mentally ill patients.
  • Neurodevelopmental liabilities in schizophrenia and affective disorders.
  • Neuropeptides involved in the pathophysiology of schizophrenia and major depression.
  • Human genetic variation and mental disorders.
  • No association of mutations and mRNA expression of WFS1/wolframin with bipolar disorder in humans.
  • The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia.
  • Schizophrenia patients' and psychiatrists' perspectives on ethical aspects of symptom re-emergence during psychopharmacological research participation.
  • Schizophrenic Patients and Cocaine Use: Antecedents to Hospitalization and Course of Treatment.
  • Heritable differences in the dopaminergic regulation of sensorimotor gatingI. Apomorphine effects on startle gating in albino and hooded outbred rat strains and their F1 and N2 progeny.
  • Impaired strategic regulation of contents of conscious awareness in schizophrenia.
  • Theory, methods and new directions in the psychophysiology of the schizophrenic process and schizotypy.
  • Relevance of drug use in clinical manifestations of schizophrenia
  • Increased developmental deviance and premorbid dysfunction in early onset schizophrenia.
  • An examination of variation in long-term community tenure after psychiatric hospitalization in eight states.
  • Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
  • Sex differences in the corpus callosum of patients with schizophrenia.
  • Sleep architecture and its clinical correlates in first episode and neuroleptic-naive patients with schizophrenia.
  • Musical hallucinations in schizophrenia. 2. Relations with verbal hallucinations.
  • The 5-HT(1A) receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice.
  • Acute and transient psychotic disorders: comparison with schizophrenia.
  • Schizoaffective disorder: clinical aspects, differential diagnosis, and treatment.
  • Attitudes towards people with a mental disorder: a survey of the Australian public and health professionals.
  • Correlations between negative symptoms and peripheral G protein levels in mononuclear leukocytes of deficit and nondeficit schizophrenics. Preliminary results.
  • Scharfetter's EPP (Ego-Psychopathology) questionnaire in Polish setting
  • Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia.
  • Childhood central nervous system viral infections and adult schizophrenia.
  • Substance use disorder comorbidity among inpatient youths with psychiatric disorder.
  • Two clusters of serum midkine levels in drug-naive patients with schizophrenia.
  • Schizophrenia, psychotic illness and other psychiatric symptoms in families with autosomal dominant nocturnal frontal lobe epilepsy caused by different mutations.
  • Synapse-Associated Protein 90/Postsynaptic Density-95-Associated Protein (SAPAP) is Expressed Differentially in Phencyclidine-Treated Rats and is Increased in the Nucleus Accumbens of Patients with Schizophrenia.
  • Null mutation of the arginine-vasopressin gene in rats slows attentional engagement and facilitates response accuracy in a lateralized reaction time task.
  • Association between psychotic disorder and urban place of birth is not mediated by obstetric complications or childhood socio-economic position: a cohort study.
  • Gonadectomy in adult life increases tyrosine hydroxylase immunoreactivity in the prefrontal cortex and decreases open field activity in male rats.
  • Towards a theory of interrupted feelings.
  • Psychological mechanisms of communication disorders in schizophrenics and their relatives
  • Electroconvulsive therapy in Hong Kong: rates of use, indications, and outcome.
  • abst 262
  • The public attitudes towards schizophrenia in a rural area in Turkey
  • At issue: predicting drug-free treatment response in acute psychosis from the Soteria project.
  • Estimating the costs and benefits of new drug therapies: atypical antipsychotic drugs for schizophrenia.
  • Are communication deviance and expressed emotion related to family history of psychiatric disorders in schizophrenia?
  • abst 267
  • Heterogeneity of admission history among patients with bipolar disorder.
  • A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors.
  • Are impaired childhood motor skills a risk factor for adolescent anxiety? Results from the 1958 U.K. birth cohort and the National Child Development Study.
  • Premorbid IQ and schizophrenia. Increasing cognitive reduction by episodes.
  • Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort.
  • Coenesthesia - an important differential diagnosis in chronic pain syndromes
  • A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain.
  • Delineating novel signature patterns of altered gene expression in schizophrenia using gene microarrays.
  • Anticipatory planning for research participants with psychotic disorders like schizophrenia.
  • Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families.
  • Genetic analysis of a functional GRIN2A promoter (GT)n repeat in bipolar disorder pedigrees in humans.
  • Schizophrenia and diabetes mellitus: not an improbable combination
  • Mental illness and menopause: a patient and family perspective.
  • A systemic review of the European Agency for the evaluation of medicinal products (EMEA) recommendations on the conduct of clinical trials in psychiatry
  • Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia.
  • How specific are deficits in mismatch negativity generation to schizophrenia?
  • No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study.
  • Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study.
  • NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits.
  • Prevalence and detection of serious psychiatric disorder in defendants attending court.
  • Predicting changes in domain-specific quality of life of schizophrenia patients.
  • Ethnic differences in use of antipsychotic medication among Texas medicaid clients with schizophrenia.
  • A 20-year follow-up study on schizophrenia in Singapore.
  • Association between minor physical anomalies and lateral ventricular enlargement in childhood and adolescent onset schizophrenia.
  • Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia.
  • Association analysis of the genetic variants of the N-methyl D-aspartate receptor subunit 2b (NR2b) and treatment-refractory schizophrenia in the Chinese.
  • The characteristics of expressed emotion among relatives of patients with schizophrenia in Chengdu, China.
  • Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol.
  • Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.
  • Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders.
  • Familial aggregation of delusional proneness in schizophrenia and bipolar pedigrees.
  • A transcranial magnetic stimulation study of abnormal cortical inhibition in schizophrenia.
  • Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview.
  • Institutionalisation and schizophrenia in Japan: social environments and negative symptoms: Nationwide survey of in-patients.
  • Molecular cloning and characterization of human RAI1, a gene associated with schizophrenia.
  • Editor's introduction: antipsychotic prescribing practices.
  • Provisional mapping of quantitative trait loci modulating the acoustic startle response and prepulse inhibition of acoustic startle.
  • Association of APOE gene with schizophrenia in Chinese: a possible risk factor in times of malnutrition.
  • abst 301
  • Inhibition in schizophrenia: association with auditory hallucinations.
  • Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats.
  • Determining vulnerability to schizophrenia in methamphetamine psychosis using exploratory eye movements.
  • Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone.
  • Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing.
  • On the descriptive validity of ICD-10 schizophrenia: empirical analyses in the spectrum of non-affective functional psychoses.
  • Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia.
  • An investigation into age and gender differences in human Kamin blocking, using a computerized task.
  • Premorbid adjustment and neuropsychological performance in schizophrenia.
  • Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia.
  • Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia.
  • Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis?
  • Antiretroviral antibodies: implications for schizophrenia, schizophrenia spectrum disorders, and bipolar disorder.
  • Treatment for mood and anxiety disorders: quetiapine and aripiprazole.
  • Repeated variable prenatal stress alters pre- and postsynaptic gene expression in the rat frontal pole.
  • A longitudinal study of patient- and observer-rated quality of life in schizophrenia.
  • Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients.
  • Parental age and risk of schizophrenia: a case-control study.
  • Affective disorders: analysis of their comorbidity in the more frequent psychiatric disorders
  • Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: implications for state mental health policy.
  • Sociotherapy in German social law. Indication, contents, and aspects of public health
  • The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.
  • Immune Activation During Pregnancy in Rats Leads to a PostPubertal Emergence of Disrupted Latent Inhibition, Dopaminergic Hyperfunction, and Altered Limbic Morphology in the Offspring: A Novel Neurodevelopmental Model of Schizophrenia.
  • Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.
  • Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons.
  • A point of view: The need to identify an antigen in psyconeuroimmunological disorders.
  • Neuroimaging communality between schizophrenia and obsessive compulsive disorder: a putative basis for schizo-obsessive disorder?
  • Prevalence and course of schizophrenia in a Chinese rural area.
  • Basal ganglia N-acetylaspartate correlates with the performance in the procedural task 'Tower of Hanoi' of neuroleptic-naive schizophrenic patients.
  • Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia.
  • Multiplex relative risk and estimation of the number of loci underlying an inherited disease.
  • Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth.
  • Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans.
  • Evaluation of antipsychotic and concomitant medication use patterns in patients with schizophrenia.
  • Autobiographical memory and theory of mind: evidence of a relationship in schizophrenia.
  • Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy.
  • An integrative physiological approach to polyuria and hyponatraemia: a 'double-take' on the diagnosis and therapy in a patient with schizophrenia.
  • A program for managing weight gain associated with atypical antipsychotics.
  • The Friedrich-Lively Instrument to Assess the Impact of Schizophrenia on Siblings (FLIISS): Part I--instrument construction.
  • Effect of riluzole on MK-801 and amphetamine-induced hyperlocomotion.
  • Munchhausen syndrome: diagnosis and management
  • Decision making deficits in patients with first-episode and chronic schizophrenia.
  • Abnormalities of brain function during a nonverbal theory of mind task in schizophrenia.
  • Nerve growth factor auto-antibodies in the sera of mothers of schizophrenic children and children from high risk group
  • Educational intervention for the relatives of schizophrenia patients in Finland.
  • Differential Role of Serotonergic Projections Arising from the Dorsal and Median Raphe Nuclei in Locomotor Hyperactivity and Prepulse Inhibition.
  • Etiology of schizophrenia: review of genes-ambient interaction
  • Antisaccade performance is abnormal in schizophrenia patients but not in their biological relatives.
  • Differences in smooth pursuit eye movement between posttraumatic stress disorder with secondary psychotic symptoms and schizophrenia.
  • Apathy in schizophrenia: clinical correlates and association with functional outcome.
  • Cognitive behavioural group treatment for social anxiety in schizophrenia.
  • No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia.
  • Sinistrality in schizophrenia.
  • Blood zinc and copper concentrations in criminal and noncriminal schizophrenic men.
  • Factors affecting the early discharge of the indoor psychotic patients - a sociodemographic survey in a specialized institution.
  • The impact of prolactin elevation with antipsychotic medications on subjective quality of life in patients with schizophrenia.
  • Does fear of coercion keep people away from mental health treatment? Evidence from a survey of persons with schizophrenia and mental health professionals.
  • CAG-repeat length in exon 1 of KCNN3 does not influence risk for schizophrenia or bipolar disorder: a meta-analysis of association studies.
  • Increased suicide attempt rate among patients interrupting use of atypical antipsychotics.
  • Moyamoya disease in a patient with schizophrenia.
  • Psychiatric comorbidity of eating disorders in men: a national study of hospitalized veterans.
  • Transmission disequilibrium test of polymorphisms of serotonin transporter gene and schizophrenia based on family trios
  • Quetiapine in the successful treatment of schizophrenia with comorbid alcohol and drug dependence: a case report.
  • Homicide and schizophrenia: maybe treatment does have a preventive effect.
  • Stability of the diagnosis of deficit syndrome in schizophrenia.
  • Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale.
  • abst 362
  • Depression and the reintegration phase of acute schizophrenia.
  • Clothiapine in the management of schizophrenia.
  • Neuropsychological deficit in polydrug users. A preliminary report of the findings of the collaborative neuropsychological study of polydrug users.
  • The possible role of dopamine in phenothiazine-induced hypothermia in rats: an application to DA hypothesis of schizophrenia.
  • Several indices of the methylation process in schizophrenic patients
  • Does dopamine play a role in schizophrenia?
  • Fluphenazine decanoate vs oral antipsychotics: a comparison of their effectiveness in the treatment of schizophrenia as measured by a reduction in hospital readmissions.
  • Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder.
  • Acid-base balance during dosed fasting of schizophrenic patients with residual manifestations of organic lesions of the central nervous system
  • Neuroleptic interference with the cocaine cue: internal stimulus control of behavior and psychosis.
  • Psychotropic drugs as tools for clinical research into schizophrenia
  • Telemetered EEG-EOG during psychotic behaviors of schizophrenia.
  • Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia.
  • Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
  • Endorphins, dopamine, and schizophrenia.
  • The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro.
  • Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings.
  • Sleep problems and their treatment in psychosis
  • P300 amplitude over temporal regions in schizophrenia.
  • Schizophrenia: the nature of the psychological disturbance and its possible neurochemcial basis.
  • Validity of plasma factor in schizophrenia as measured by tryptophan uptake.
  • The homeless person and the psychiatric services: an Edinburgh survey.
  • NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia.
  • Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses.
  • Structure of the use of symbols in schizophrenic language
  • Development and validation of a measure of patients' knowledge about schizophrenia.
  • Some aspects of order and symbolism in schizophrenia.
  • Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice.
  • Lack of association between the hSKCa3 channel gene CAG polymorphism and schizophrenia.
  • Biogenic amine turnover and serum cholesterol in suicide attempt.
  • Association study of the 5-HT6 receptor gene in schizophrenia.
  • Sexual disturbances during clozapine and haloperidol treatment for schizophrenia.
  • Relationship between childhood behavioral disturbance and later schizophrenia in the New York High-Risk Project.
  • New methods for studying hallucinated 'voices' in schizophrenia.
  • Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2-year follow-up.
  • Elective combined electroconvulsive and clozapine therapy.
  • abst 396
  • Visualizing fronto-striatal circuitry and neuroleptic effects in schizophrenia.
  • Subjective experience in schizophrenia: factors influencing self-esteem, satisfaction with life, and subjective distress.
  • Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: implications for theories of cortical dysfunction.
  • Genetic association analysis of 5-HT(6) receptor gene polymorphism (267C/T) with tardive dyskinesia.
  • Volumetric measurements of the hippocampus and amygdala with MRI in healthy adults
  • Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
  • Attenuated frontal activation in schizophrenia may be task dependent.
  • Personality and psychopathology in schizophrenia: the association between personality traits and symptoms.
  • Cost-effectiveness index (CEI): a tool to help evaluate mental health programs.
  • Roles of brain science in psychiatry
  • Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4.
  • Search for retroviral related DNA polymorphisms using RAPD PCR in schizophrenia.
  • Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
  • Association of perceived family criticism with health behaviors.
  • Left planum temporale volume reduction in schizophrenia.
  • Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology.
  • A conjoint phase of treatment involving a severely disturbed adolescent boy and his father.
  • Impairment of consciously controlled use of memory in schizophrenia.
  • abst 412
  • Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.
  • Kallmann syndrome gene (KAL-X) is not mutated in schizophrenia.
  • Potential role of muscarinic receptors in schizophrenia.
  • Phenomenology of mania: evidence for distinct depressed, dysphoric, and euphoric presentations.
  • Immediate memory, attention and communication disturbances in schizophrenia patients and their relatives.
  • Perspective and the measurement of costs and benefits for cost-effectiveness analysis in schizophrenia.
  • Thrombocytopenia in patients with 22q11.2 deletion syndrome and its association with glycoprotein Ib-beta.
  • The experiences of people with schizophrenia living in supported accommodation: a qualitative study using grounded theory methodology.
  • Traumatic Brain Injury and Psychosis: What Is the Connection?
  • Increased automatic spreading activation in healthy subjects with elevated scores in a scale assessing schizophrenic language disturbances.
  • Symptoms and cognition as predictors of community functioning: a prospective analysis.
  • Criteria defining refractory schizophrenia.
  • Neurocognitive correlates of schizotypy in first degree relatives of schizophrenia patients.
  • Synergistic interactions between ampakines and antipsychotic drugs.
  • Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients.
  • Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.
  • Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia.
  • Clinical variables and genetic loading for schizophrenia: analysis of published Danish adoption study data.
  • Dopamine D1 receptor changes due to caesarean section birth: effects of anesthesia, developmental time course, and functional consequences.
  • Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex.
  • Neurocognitive and social functioning in schizophrenia.
  • Race in the "decade of the brain".
  • Risks and responsibilities. To make collaboration work, sponsorship modes must stress influence rather than control.
  • Attitudes of patients toward the first psychotic episode and the start of treatment.
  • Long-term follow-up of rural involuntary clients.
  • Stealth viruses as neuropathogens.
  • Symptom heterogeneity in comorbid alcohol disorder.
  • Electrodermically nonresponsive schizophrenia patients make more errors in the Stroop Color Word Test, indicating selective attention deficit.
  • Effect of synthetic substance P on monoaminergic mechanisms in brain.
  • Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations.
  • Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal.
  • Isolation-rearing of rats produces deficits as adults in the serotonergic innervation of hippocampus.
  • Touch feel illusion in schizophrenic patients.
  • Genome scan for susceptibility loci for schizophrenia.
  • Smooth pursuit eye tracking over a structured background in first-episode schizophrenic patients.
  • Perspectives of women living with schizophrenia.
  • Attempted suicide and alcoholism in bipolar disorder: clinical and familial relationships.
  • Prefrontal structural and functional deficits in schizotypal personality disorder.
  • First-episode schizophreniform disorder: comparisons with first-episode schizophrenia.
  • Ethical issues in schizophrenia research.
  • Multisensory auditory-visual interactions during early sensory processing in humans: a high-density electrical mapping study.
  • Electroencephalogram and repetitive transcranial magnetic stimulation.
  • The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex.
  • At issue: management of medication noncompliance in schizophrenia by families in India.
  • Schizotypy: phenotypic marker as risk factor.
  • abst 454
  • Presymptomatic screening for schizophrenia: a geneticist's perspective.
  • Screening for low prevalence disorders.
  • Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia: a post-mortem study.
  • abst 458
  • Magnetic resonance imaging of the thalamus in first-episode psychosis.
  • Symptom clusters in the diagnosis of affective disorder, schizoaffective disorder, and schizophrenia in African Americans.
  • Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia.
  • Self-construal among psychiatric outpatients: a test of the golden section.
  • Differences in fMRI and MRS in a monozygotic twin pair discordant for schizophrenia (case report).
  • abst 463
  • Stability and course of neuropsychological deficits in schizophrenia.
  • Factors connected with the effect of risperidone on psychopathological symptoms and working memory in schizophrenia
  • Population variation in children's behavioral symptomatology.
  • Association analysis of a functional catechol-o-methyltransferase gene polymorphism in schizophrenic patients in Taiwan.
  • Basic symptoms and their contribution to the differential typology of acute schizophrenic and schizoaffective disorders.
  • A proposed pathological model in the hippocampus of subjects with schizophrenia.
  • Criminal behavior of forensic and general psychiatric patients with schizophrenia: are they different?
  • Combined use of risperidone and olanzapine in the treatment of patients with resistant schizophrenia: a preliminary case series report.
  • Clara cell secretory protein (CC16) gene polymorphism and schizophrenia in humans.
  • Cranial MR imaging of sequelae of prefrontal lobotomy.
  • GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons.
  • Natural course of schizophrenia: 2-year follow-up study in a rural Chinese community.
  • Elevated dopamine receptor-coupled G(s) protein measures in mononuclear leukocytes of patients with schizophrenia.
  • Relationship of extrapyramidal symptoms to age at onset and drug treatment in middle-aged and elderly schizophrenic patients.
  • Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex.
  • Comparison between a SCAN diagnosis and a clinical diagnosis
  • Fixation stability in schizophrenia, bipolar, and control subjects.
  • Isolation rearing in the rat disrupts the hippocampal response to stress.
  • Expression of AMPA receptor flip and flop mRNAs in the nucleus accumbens and prefrontal cortex after neonatal ventral hippocampal lesions.
  • Glycine reduces novelty- and methamphetamine-induced locomotor activity in neonatal ventral hippocampal damaged rats.
  • HIT, hallucination focused integrative treatment as early intervention in psychotic adolescents with auditory hallucinations: a pilot study.
  • Hyperactivity and impaired response habituation in hyperdopaminergic mice.
  • Animal models with construct validity for schizophrenia.
  • Diagnosing schizophrenia in the initial prodromal phase.
  • Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes.
  • Predicting community survival in early psychosis and schizophrenia populations after receiving intensive case management.
  • Anhedonia in schizophrenia: a distinct familial subtype?
  • Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia.
  • Early maternal deprivation and prepulse inhibition: the role of the postdeprivation environment.
  • A case of leukopenia in treatment with risperidone in an adolescent
  • The paradox of normal neuropsychological function in schizophrenia.
  • D-Cycloserine, a positive modulator of NMDA receptors, inhibits serotonergic function.
  • Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression.
  • Depression and stigma
  • Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model.
  • Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study.
  • Cognitive function in euthymic bipolar patients, stabilized schizophrenic patients, and healthy controls.
  • Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives.
  • Quality measures for mental health care: results from a national inventory.
  • Actual situation and social prognosis of women seeking psychiatric care at the emergency hostel of Tokyo Metropolitan Women's Counseling Center
  • Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex.
  • A confirmatory factor analytic evaluation of the pentagonal PANSS model.
  • Selection bias in clinical trials with antipsychotics.
  • Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders
  • Blockade of NMDA receptors in the amygdala prevents latent inhibition of fear-conditioning.
  • abst 504
  • Pituitary and peripheral resistance to thyroid hormone.
  • Psychoses and borderline cases in puberty and adolescence and their importance in criminal law
  • Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients.
  • Planimetric volumetry of human brains
  • Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation.
  • Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study.
  • Age-at-first-registration and heterogeneity in affective psychoses.
  • Comparative post-mortem study of cavum septi pellucidi in alcoholics, schizophrenics and aggressive persons.
  • Severe self-injurious behavior associated with treatment-resistant schizophrenia: treatment with maintenance electroconvulsive therapy.
  • Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia.
  • Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises.
  • Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
  • Current perception thresholds and postoperative pain in schizophrenic patients.
  • The development of mental health care pathways: friend or foe?
  • Expressed emotion and family distress in relatives of patients with schizophrenia in Japan.
  • Association study between interleukin-1beta gene (IL-1beta) and schizophrenia.
  • Alterations in tonotopy and auditory cerebral asymmetry in schizophrenia.
  • Verbal processing deficits in schizophrenia.
  • Associated deficits in mismatch negativity generation and tone matching in schizophrenia.
  • Mental disorders in acute neuroleptic poisoning
  • A survey of drug utilization in psychiatric hospitals in Japan: comparison of 1973, 1979, and 1993
  • Effects of chewing betel nut (Areca catechu) on the symptoms of people with schizophrenia in Palau, Micronesia.
  • Dopamine D(2) receptor blockade by haloperidol. (3)H-raclopride reveals much higher occupancy than EEDQ.
  • Computerized brain tomography in patients with Schizophrenia.
  • Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia.
  • No evidence for a parent-of-origin effect detected in the pattern of inheritance of schizophrenia.
  • Relation of intelligence and religiosity to depressive disorders in offspring of depressed and nondepressed mothers.
  • Characterisation, mutation detection, and association analysis of alternative promoters and 5' UTRs of the human dopamine D3 receptor gene in schizophrenia.
  • abst 530
  • Relationship between psychotic disorders in adolescence and criminally violent behaviour. A retrospective examination.
  • Neonatal treatment with L-name (NG-nitro-L-arginine methyl ester) attenuates stereotyped behavior induced by acute methamphetamine but not development of behavioral sensitization to methamphetamine.
  • Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome.
  • Genetic approaches to polydipsia in schizophrenia: A preliminary report of a family study and an association study of an angiotensin-converting enzyme gene polymorphism.
  • Theta rhythm increases in left superior temporal cortex during auditory hallucinations in schizophrenia: a case report.
  • Assessing positive and negative symptoms in outpatients with schizophrenia and mood disorders.
  • Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.
  • Mental health literacy in Singapore: a comparative survey of psychiatrists and primary health professionals.
  • Apolipoprotein E in schizophrenia: A French association study and meta-analysis.
  • Sexual side effects of novel antipsychotic medications.
  • Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms.
  • Ketamine effects on eye movements.
  • Natural evolution of paranoid schizophrenia treated consecutively with 4 different neuroleptics
  • Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis.
  • Late component ERPs are associated with three syndromes in schizophrenia.
  • Birth insult alters dopamine-mediated behavior in a precocial species, the guinea pig. Implications for schizophrenia.
  • Estradiol levels in psychotic disorders.
  • Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging.
  • A delphi approach to characterising "relapse" as used in UK clinical practice.
  • abst 549
  • Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital.
  • The effects of DCG-IV and L-CCG-1 upon phencyclidine (PCP)-induced locomotion and behavioral changes in mice
  • A young adult female case of Wilson's disease presenting with mental disorder and frontal lobe signs
  • A prognostic study of clinical dimensions in adolescent-onset psychoses.
  • abst 553
  • Neuropsychological deficit in siblings discordant for schizophrenia.
  • Long-term trends of symptoms and disability in schizophrenia and related disorders.
  • Distinct functions of the two isoforms of dopamine D2 receptors.
  • Exploratory eye movements in schizophrenia: effects of figure size and the instruction on visual search.
  • Independence and overlap among neurocognitive correlates of community functioning in schizophrenia.
  • On the epigenetic regulation of the human reelin promoter.
  • N400 and automatic semantic processing abnormalities in patients with schizophrenia.
  • MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder.
  • 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia.
  • Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and 11Craclopride.
  • The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study.
  • Use of general medical services by VA patients with psychiatric disorders.
  • A comparison of guidelines for the treatment of schizophrenia.
  • A polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: lack of association.
  • An interstitial deletion of the long arm of chromosome 21 in a case of a first episode of psychosis.
  • Diagnostic outcome of self-reported hallucinations in a community sample of adolescents.
  • Neurochemical changes and neurotoxic effects of an acute treatment with sydnocarb, a novel psychostimulant: comparison with D-amphetamine.
  • Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophrenia.
  • abst 69
  • A mass of flesh: schizophrenic Rorschach percepts.
  • The cognitive structure of higher functioning autism and schizophrenia: a comparative study.
  • Affinity and specificity of N-methyl- D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats.
  • Eye movements during the Rorschach test in schizophrenia.
  • Substance abuse in schizophrenia. A Singapore perspective.
  • Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes.
  • Exposure to prenatal infections, genetics and the risk of systematic and periodic catatonia.
  • Permutation tests for detecting and estimating mixtures in task performance within groups.
  • Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment.
  • abst 78
  • abst 79
  • Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.
  • Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia.
  • A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia.
  • IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow-up.
  • Adaptation to chronic PCP results in hyperfunctional NMDA and hypofunctional GABA(A) synaptic receptors.
  • Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone.
  • The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia.
  • Depression in paranoid and nonparanoid schizophrenic patients compared with major depressive disorder.
  • Two cases of infectious mononucleosis-like syndrome associated with human herpes-virus 6
  • Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration.
  • abst 89
  • Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain.
  • Chronic cocaine administration reduces phospholipase A(2) activity in rat brain striatum.
  • Neuregulin 1 and susceptibility to schizophrenia.
  • Emotional behavior in schizophrenia and one-sided brain damage. Cerebral hemispheric asymmetry. Part I
  • Mismatch negativity in chronic schizophrenia and first-episode schizophrenia.
  • Diagnostic reliability of bipolar II disorder.
  • Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity.
  • abst 96
  • Auditory hallucinations: hypothesis in the context of spread spectrum communications.
  • Consent and long-term neuroleptic treatment.
  • An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia.
  • Membrane Na(+)-K+ ATPase mediated cascade in bipolar mood disorder, major depressive disorder, and schizophrenia--relationship to hemispheric dominance.








    Vitamins, amino acids, oils for topical application, and prescription medications...
    There are a number of approaches to hair loss problems.
    Hair Million is an herbal alternative. It is a formula made of traditional, edible herbs and has been anecdotally demonstrated the efficacy to ward off hair loss problems.

    There is no singular medical or alternative cure for hair loss since the biology of hair growth is a highly complicated phenomenon. It is unknown how Hair Million stops hair loss, and promotes hair restoration. The advantages of Hair Million over other approaches are, firstly, Hair Million is comparatively inexpensive, and secondly, it is made only of traditionally used safe and healthy herbs that promote hair growth according to Chinese pharmacopoeia. In addition, Hair Million is cardiotonic, meaning that Hair Million consists of herbs that strengthens your heart, according to Chinese medicine. There is an interesting research paper which correlates baldness to heart diseases: people with alopecia or hair loss problems are significantly more likely to develop heart attacks.









    DHEA is a natural hormone, and it is produced in our body by the adrenal glands. DHEA has been suggested to provide numerous potential benefits. DHEA (or dehydroepiandrosterone) is converted into androgens (male hormones) or estrogens (female hormones) in the cells.





    DreamPharm Online Healthy Supplements || Lutein || Progesterone Cream || Natural herbal formula for hair loss problems ||